GeneDx (WGS) Proxy filing summary

Voting matters and shareholder proposals

• Election of Katherine Stueland as director is up for shareholder vote, with board recommending approval.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026 is proposed.

• Advisory vote on executive compensation for named executive officers is included.

• Advisory vote on the frequency of future say-on-pay votes (every 1, 2, or 3 years) is presented.

• Other business may be addressed as appropriate during the meeting or any adjournment.

Board of directors and corporate governance

• Katherine Stueland is nominated for election to the board.

Executive compensation and say-on-pay

• Shareholders will vote on a non-binding advisory basis to approve compensation for named executive officers.

• Shareholders will indicate preferred frequency for future advisory votes on executive compensation.